Population pharmacodynamic model for low molecular weight heparin nadroparin in morbidly obese and non-obese patients using anti-Xa levels as endpoint
Diepstraten, Jeroen, Janssen, Esther J. H., Hackeng, Christian M., van Dongen, Eric P. A., Wiezer, René J., van Ramshorst, Bert, Knibbe, Catherijne A. J.Volume:
71
Language:
english
Journal:
European Journal of Clinical Pharmacology
DOI:
10.1007/s00228-014-1760-4
Date:
January, 2015
File:
PDF, 664 KB
english, 2015